[1] XF Pan, Wang L, Pan A. Epidemiology and determinants of obesity in China[J]. Lancet Diabetes Endocrinol, 2021, 9(6): 373-392. [2] 席波.综合防控儿童肥胖遏制潜在健康危害[J].中国学校卫生,2024,45(10): 1369-1371,1377. Xi B.Comprehensive prevention and management of childhood obesity to reduce potential adverse health outcome[J].Chin J Sch Health,2024,45(10): 1369-1371,1377.(in Chinese) [3] 陈宜人,吴丽君,陈芳芳.脂质组学分析方法在儿童健康与疾病中的应用[J].中国儿童保健杂志,2023,31(10): 1091-1095. Chen YR, WU LJ, Chen FF. Application of lipidomics analy-sis in children's health and diseases[J]. Chin J Child Health Care, 2023, 31(10): 1091-1095. (in Chinese) [4] V Hainer, Toplak H, Mitrakou A. Treatment modalities of obesity:What fits whom[J]. Diabetes Care, 2008, 31(2): S269-S277. [5] AM Chao, Quigley KM, Wadden TA. Dietary interventions for obesity: Clinical and mechanistic findings[J]. J Clin Invest, 2021, 131(1): e140065. [6] G Fiore, Pascuzzi MC, Di Profio E, et al. Bioactive compounds in childhood obesity and associated metabolic complications: Current evidence, controversies and perspectives[J]. Pharmacol Res, 2023, 187: 106599. [7] Lassandro C, Banderali G, Radaelli G, et al. Docosahexaenoic acid levels in blood and metabolic syndrome in obese children: Is there a link?[J]. Int J Mol Sci, 2015, 16(8): 19989-20000. [8] Wang L, Manson JE, Rautiainen S, et al. A prospective study of erythrocyte polyunsaturated fatty acid, weight gain, and risk of becoming overweight or obese in middle-aged and older women[J]. Eur J Nutr, 2016, 55(2): 687-697. [9] Africa JA, Newton KP, Schwimmer JB. Lifestyle interventions including nutrition, exercise, and supplements for nonalcoholic fatty liver disease in children[J]. Dig Dis Sci, 2016, 61(5): 1375-1386. [10] Chen W, Ao Y, Lan X, et al. Associations of specific dietary unsaturated fatty acids with risk of overweight/obesity: Population-based cohort study[J]. Front Nutr, 2023, 10: 1150709. [11] Jazayeri S, Heshmati J, Mokhtari Z, et al. Effect of omega-3 fatty acids supplementation on anthropometric indices in children and adolescents: A systematic review and meta-analysis of randomized controlled trials[J]. Complement Ther Med, 2020, 53: 102487. [12] Huang Z, Ma K, Yin X, et al. The associations of fatty acids related dietary patterns with overweight and obesity among Chinese children[J]. J Health Popul Nutr, 2024, 43(1): 54. [13] AP Simopoulos. An increase in the omega-6/omega-3 fatty acid ratio increases the risk for obesity[J]. Nutrients, 2016, 8(3): 128-145. [14] Verduci E, Radaelli G, Salvioni M, et al. Plasma long-chain fatty acids profile and metabolic outcomes in normolipidaemic obese children after one-year nutritional intervention[J]. Acta Paediatr, 2011, 100(4): 585-589. [15] Emdin CA, Khera AV, Kathiresan S. Mendelian randomization[J]. JAMA, 2017, 318(19): 1925-1926. [16] Grover S. Mendelian randomization: Methods for using genetic variants in causal estimation [M]. London, UK: Chapman & Hall/CRC Press, 2015. [17] Smith GD, Ebrahim S. 'Mendelian randomization': Can genetic epidemiology contribute to understanding environmental determinants of disease[J]. Int J Epidemiol, 2003, 32(1): 1-22. [18] Skrivankova VW, Richmond RC, Woolf BAR, et al. Strengthening the reporting of observational studies in epidemiology using mendelian randomization: The STROBE-MR statement[J]. JAMA, 2021, 326(16): 1614-1621. [19] Richardson TG, Leyden GM, Wang Q, et al. Characterising metabolomic signatures of lipid-modifying therapies through drug target mendelian randomisation[J]. PLoS Biol, 2022, 20(2): e3001547. [20] Bradfield JP, Taal HR, Timpson NJ, et al. A genome-wide association meta-analysis identifies new childhood obesity loci[J]. Nat Genet, 2012, 44(5): 526-531. [21] Hampl SE, Hassink SG, Skinner AC, et al. Clinical practice guideline for the evaluation and treatment of children and adolescents with obesity[J]. Pediatrics, 2023, 151(2): e2022060641. [22] Sekula P, Del Greco MF, Pattaro C, et al. Mendelian randomization as an approach to assess causality using observational data[J]. J Am Soc Nephrol, 2016, 27(11): 3253-3265. [23] Hartwig FP, Davies NM, Hemani G, et al. Two-sample Mendelian randomization: Avoiding the downsides of a powerful, widely applicable but potentially fallible technique[J]. Int J Epidemiol, 2016, 45(6): 1717-1726. [24] Burgess S, Thompson SG. Bias in causal estimates from Mendelian randomization studies with weak instruments[J]. Stat Med, 2011, 30(11): 1312-1323. [25] Slob EAW, Burgess S. A comparison of robust Mendelian randomization methods using summary data[J]. Genet Epidemiol, 2020, 44(4): 313-329. [26] Burgess S, Dudbridge F, Thompson SG. Combining information on multiple instrumental variables in Mendelian randomization: Comparison of allele score and summarized data methods[J]. Stat Med, 2016, 35(11): 1880-1906. [27] Selvaraju V, Venkatapoorna CMK, Babu JR, et al. Salivary amylase gene copy number is associated with the obesity and inflammatory markers in children[J]. Diabetes Metab Syndr Obes, 2020, 13: 1695-1701. [28] Purdy JC, Shatzel JJ. The hematologic consequences of obesity[J]. Eur J Haematol, 2021, 106(3): 306-319. [29] de Farias Fraga G, da Silva Rodrigues F, Jantsch J, et al. Omega-3 attenuates disrupted neurotransmission and partially protects metabolic dysfunction caused by obesity in wistar rats[J]. Neurochem Res, 2024, 49(10): 2763-2773. [30] Albracht-Schulte K, Kalupahana NS, Ramalingam L, et al.Omega-3 fatty acids in obesity and metabolic syndrome: a mechanistic update[J]. J Nutr Biochem, 2018, 58: 1-16. [31] Djuricic I, Calder PC. Beneficial outcomes of omega-6 and omega-3 polyunsaturated fatty acids on human health: An update for 2021[J]. Nutrients, 2021, 13(7): 2421. [32] Zhang YY, Liu W, Zhao TY, et al. Efficacy of omega-3 polyunsaturated fatty acids supplementation in managing overweight and obesity: A Meta-analysis of randomized clinical trials[J]. J Nutr Health Aging, 2017, 21(2): 187-192. [33] Gray B, Steyn F, Davies PS, et al. Omega-3 fatty acids: A review of the effects on adiponectin and leptin and potential implications for obesity management[J]. Eur J Clin Nutr, 2013, 67(12): 1234-1242. [34] Lepretti M, Martucciello S, Burgos Aceves-MA, et al. Omega-3 fatty acids and insulin resistance: Focus on the regulation of mitochondria and endoplasmic reticulum stress[J]. Nutrients, 2018, 10(3): 350. [35] HM O'Neill, Holloway GP, Steinberg GR. AMPK regulation of fatty acid metabolism and mitochondrial biogenesis: Implications for obesity[J]. Mol Cell Endocrinol, 2013, 366(2): 135-151. [36] Santamarina AB, Mennitti LV, de Souza EA, et al. A low-carbohydrate diet with different fatty acids' sources in the treatment of obesity: Impact on insulin resistance and adipogenesis[J]. Clin Nutr, 2023, 42(12): 2381-2394. [37] B Virgolici, Popescu LA, Virgolici HM, et al. Effects of omega-3 fatty acids associated with antioxidant vitamins in overweight and obese children[J]. Acta Endocrinol (Buchar), 2023, 19(2): 221-227. [38] Kalupahana NS, Goonapienuwala BL, Moustaid-Moussa N. Omega-3 fatty acids and adipose tissue: Inflammation and browning[J]. Annu Rev Nutr, 2020, 40: 25-49. [39] Saini RK, Keum YS. Omega-3 and omega-6 polyunsaturated fatty acids: Dietary sources, metabolism, and significance - A review[J]. Life Sci, 2018, 203: 255-267. [40] Simopoulos AP. Dietary omega-3 fatty acid deficiency and high fructose intake in the development of metabolic syndrome, brain metabolic abnormalities, and non-alcoholic fatty liver disease[J]. Nutrients, 2013, 5(8): 2901-2923. [41] Simopoulos AP. The importance of the ratio of omega-6/omega-3 essential fatty acids[J]. Biomed Pharmacother, 2002, 56(8): 365-379. [42] Dyall SC, Balas L, Bazan NG, et al. Polyunsaturated fatty acids and fatty acid-derived lipid mediators: Recent advances in the understanding of their biosynthesis, structures, and functions[J]. Prog Lipid Res, 2022, 86: 101165. [43] Das UN. Biological significance of essential fatty acids[J]. J Assoc Physicians India, 2006, 54: 309-319. [44] Schwinkendorf DR, Tsatsos NG, Gosnell BA, et al. Effects of central administration of distinct fatty acids on hypothalamic neuropeptide expression and energy metabolism[J]. Int J Obes (Lond), 2011, 35(3): 336-344. [45] Lepperdinger G. Inflammation and mesenchymal stem cell aging[J]. Curr Opin Immunol, 2011, 23(4): 518-524. [46] Patterson E, Wall R, Fitzgerald GF, et al. Health implications of high dietary omega-6 polyunsaturated fatty acids[J]. J Nutr Metab, 2012, 2012: 539426. [47] Vahdaninia M, Mackenzie H, Dean T, et al. The effectiveness of ω-3 polyunsaturated fatty acid interventions during pregnancy on obesity measures in the offspring: An up-to-date systematic review and meta-analysis[J]. Eur J Nutr, 2019, 58(7): 2597-2613. [48] Rudolph MC, Young BE, Lemas DJ, et al. Early infant adipose deposition is positively associated with the n-6 to n-3 fatty acid ratio in human milk independent of maternal BMI[J]. Int J Obes (Lond), 2017, 41(4): 510-517. [49] Simopoulos AP. The impact of the Bellagio Report on healthy agriculture, healthy nutrition, healthy people: Scientific and policy aspects and the international network of centers for genetics, nutrition and fitness for health[J]. J Nutrigenet Nutrigenomics, 2014, 7(4-6): 191-211. [50] Mahmood L, Flores-Barrantes P, Moreno LA, et al. The influence of parental dietary behaviors and practices on children's eating habits[J]. Nutrients, 2021, 13(4): 1138. [51] Bender N, Portmann M, Heg Z, et al. Fish or n3-PUFA intake and body composition:A systematic review and meta-analysis[J]. Obes Rev, 2014, 15(8): 657-665. |